You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The agency is providing the material freely and asking for feedback, so it can fix possible problems before more widely disseminating it to labs and companies.
The public-private partnership has published a paper on a list of indels larger than 50 bp that is already being used to develop new methods.
The US Senate has unanimously passed a $2 trillion stimulus package to address the coronavirus, the New York Times reports.
Having raised $1.5 million in funding since announcing the project at a 2017 AACR meeting, the group anticipates completing the first phase of the project by Q2 2020.
Investigators concluded that the spiked samples from SeraCare were a robust tool for inter-lab comparisons and discussed some areas of discordance seen in the study.
A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.
The methods address challenges like recall and precision, comparing different representations of variant calls, and stratifying performance by variant type and genome context.
Researchers may experience the effects of the government shutdown for a while, the Los Angeles Times reports.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.